. Kaplan-Meier analysis of miR-451a expression among LUSQ patients with adjusting clinical stage and age distribution. Kaplan-Meier curve of 5-year overall survival and 5-year disease-free survival according to miR-451a expression among patients with LUSQ in TCGA database (p = 0.026 and p = 0.024, respectively). Clinical stage and patient's age were adjusted and analyzed. Patients were divided into high (red) and low (blue) expression groups. (miR-451a and miR-144-5p) was an independent predictive factor for survival of the patients. For this analysis, patients were divided in half by expression levels of miRNA among TCGA database and were merged by patients ID.
. Kaplan-Meier analysis of miR-451a expression among LUSQ patients with adjusting clinical stage and age distribution. Kaplan-Meier curve of 5-year overall survival and 5-year disease-free survival according to miR-451a expression among patients with LUSQ in TCGA database (p = 0.026 and p = 0.024, respectively). Clinical stage and patient's age were adjusted and analyzed. Patients were divided into high (red) and low (blue) expression groups. -451a, miR-144-3p and miR-144-5p in the patients with LUSQ. (A) Forest plot of univariate Cox proportional hazards regression analysis of 5-year overall survival. (B) Multivariate Cox proportional hazards regression analysis of 5-year overall survival using TCGA database. High expression of 2 miRNAs (miR-451a and miR-144-5p) was an independent predictive factor for survival of the patients. For this analysis, patients were divided in half by expression levels of miRNA among TCGA database and were merged by patients ID. 
